Both in Biotechnology
Jasper Therapeutics vs Black Hawk Acquisition
Over the past year JSPR returned −77.0% and BKHA returned −60.3%; their daily moves had a correlation of -0.03.
JSPR −77.0% BKHA −60.3%Growth of $1, one year, split-adjusted
| Metric | JSPR | BKHA |
|---|---|---|
| Price | $0.5388 | $4.58 |
| Market cap | $17.9M | $19.0M |
| Today | +3.83% | −7.29% |
| 1 month | −13.8% | −62.9% |
| 6 months | −39.5% | — |
| Year to date | −70.6% | −59.3% |
| 1 year | −76.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 84.1% | 153.2% |
| Short % of float | 22.6% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).